The initial validation of ADCT was conducted with adult patients in the US. Patients should use ADCT in their own language. Therefore, ADCT is available in 50 country-specific languages. Translation of the tool into any language includes language validation. The linguistic validations have been performed by a third-party vendor – MAPI Research Trust.
If your language is not currently included in the list of languages below, please reach out to MAPI Research Trust to submit a request: https://eprovide.mapi-trust.org/instruments/atopic-dermatitis-control-tool